Skip to main content

Table 2 Tolerance time at FIRST interview by patients’ characteristics (n = 232)a

From: Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer

Variable Category Tolerance time at FIRST interview (n = 232)a Total
n (%)
P-value
No time period (n = 36)
n (%)
Months(n = 96)
n (%)
Years(n = 100)
n (%)
Age group (years) ≤ 60 years 9 (25.0) 20 (20.8) 22 (22.0) 51 (21.7) 0.9788
61–70 years 12 (33.3) 37 (38.5) 36 (36.0) 85 (36.2)
> 70 years 15 (41.7) 39 (40.6) 42 (42.0) 96 (41.4)
Gender Male 24 (66.7) 55 (57.3) 50 (50.0) 129 (55.6) 0.2052
Female 12 (33.3) 41 (42.7) 50 (50.0) 103 (44.4)
Race White or Caucasian 33 (91.7) 93 (96.9) 95 (95.0) 221 (95.3) 0.5415**
Black/African-American 2 (5.6) 2 (2.1) 2 (2.0) 6 (2.6)
Other 1 (2.8) 1 (1.0) 3 (3.0) 5 (2.2)
Educationa Less than high school or high school diploma or GED degree 21 (61.8) 49 (51.6) 49 (50.5) 119 (52.7) 0.5081
Some college or bachelor’s or higher degree 13 (38.2) 46 (48.4) 48 (49.5) 107 (47.3)
Employment Working 10 (27.8) 25 (26.0) 25 (25.0) 60 (25.9) 0.9468
Not working 26 (72.2) 71 (74.0) 75 (75.0) 172 (74.1)
Marital statusa Married 19 (52.8) 68 (71.6) 58 (58.0) 145 (62.8) 0.0588
Not married 17 (47.2) 27 (28.4) 42 (42.0) 86 (37.2)
Incomea Annual income $45,000 or more 10 (41.7) 34 (50.0) 24 (40.0) 68 (44.7) 0.4971
Annual income less than $45,000 14 (58.3) 34 (50.0) 36 (60.0) 84 (55.3)
Primary method of payment Private insurance 9 (25.0) 33 (34.4) 32 (32.0) 74 (31.9) 0.1993
Medicare 20 (55.6) 50 (52.1) 48 (48.0) 118 (50.9)
Medicaid 3 (8.3) 11 (11.5) 8 (8.0) 22 (9.5)
Others 4 (11.1) 2 (2.1) 12 (12.0) 18 (7.8)
Urban/Rural Urban 25 (69.4) 66 (68.8) 62 (62.0) 153 (65.9) 0.5418
Rural 11 (30.6) 30 (31.2) 38 (38.0) 79 (34.1)
  1. **Uses Fisher’s Exact Test
  2. aExcludes cases where values were not reported (n = 1, for Marital status; n = 2 for Income)